1. Home
  2. HUN vs STOK Comparison

HUN vs STOK Comparison

Compare HUN & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$11.73

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.84

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
STOK
Founded
1970
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
HUN
STOK
Price
$11.73
$32.84
Analyst Decision
Hold
Strong Buy
Analyst Count
11
10
Target Price
$10.23
$34.10
AVG Volume (30 Days)
4.2M
795.7K
Earning Date
02-17-2026
11-04-2025
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
$5,780,000,000.00
$205,632,000.00
Revenue This Year
N/A
$430.24
Revenue Next Year
$3.31
N/A
P/E Ratio
N/A
$47.98
Revenue Growth
N/A
1128.17
52 Week Low
$7.30
$5.35
52 Week High
$18.53
$38.69

Technical Indicators

Market Signals
Indicator
HUN
STOK
Relative Strength Index (RSI) 73.03 52.37
Support Level $9.90 $29.75
Resistance Level $11.32 $37.34
Average True Range (ATR) 0.45 1.76
MACD 0.11 -0.00
Stochastic Oscillator 94.96 39.30

Price Performance

Historical Comparison
HUN
STOK

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: